Save information for later
Sign Up

Learn About Cramp-Fasciculation Syndrome

Who are the top Cramp-Fasciculation Syndrome Local Doctors?
Elite in Cramp-Fasciculation Syndrome
Elite in Cramp-Fasciculation Syndrome

Krankenanstalt Rudolfstiftung

Vienna, AT 

C Stollberger practices in Vienna, Austria. Stollberger and is rated as an Elite expert by MediFind in the treatment of Cramp-Fasciculation Syndrome. Their top areas of expertise are Cardiomyopathy, Endocardial Fibroelastosis, Cramp-Fasciculation Syndrome, Heart Transplant, and Embolectomy.

Elite in Cramp-Fasciculation Syndrome
Elite in Cramp-Fasciculation Syndrome
Brussels, BRU, BE 

Michel Toussaint practices in Brussels, Belgium. Mr. Toussaint and is rated as an Elite expert by MediFind in the treatment of Cramp-Fasciculation Syndrome. His top areas of expertise are Cramp-Fasciculation Syndrome, Swallowing Difficulty, Duchenne Muscular Dystrophy, and Becker Muscular Dystrophy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Cramp-Fasciculation Syndrome
Elite in Cramp-Fasciculation Syndrome
Munich, BY, DE 

Benedikt Schoser practices in Munich, Germany. Mr. Schoser and is rated as an Elite expert by MediFind in the treatment of Cramp-Fasciculation Syndrome. His top areas of expertise are Myotonic Dystrophy Type 2, Myotonic Dystrophy, Paramyotonia Congenita, Pompe Disease, and Thymectomy.

What are the latest Cramp-Fasciculation Syndrome Clinical Trials?
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)

Summary: This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Environmental Risk Factors for the Anti-Synthetase Syndrome

Background: * Like other complex diseases, autoimmune diseases are the result of numerous causes, including genetic and environmental factors. Some researchers believe that people who are susceptible to autoimmune disorders develop them when the body reacts to environmental or other factors by creating white blood cells that attack the body s own tissues, which then progresses to autoimmune diseases. These im...

Who are the sources who wrote this article ?

Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center